Free Trial

Alpha Real Trust (ARTL) Competitors

Alpha Real Trust logo
GBX 202.50 +21.50 (+11.88%)
As of 12:40 PM Eastern

ARTL vs. SLN, AMYT, GPH, IGC, PHAR, KOD, ORPH, AMPH, ANW, and REVB

Should you be buying Alpha Real Trust stock or one of its competitors? The main competitors of Alpha Real Trust include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Global Ports (GPH), India Capital Growth (IGC), Pharos Energy (PHAR), Kodal Minerals (KOD), Open Orphan (ORPH), Aggregated Micro Power (AMPH), Aberdeen New Thai Investment Trust (ANW), and Revolution Beauty Group (REVB). These companies are all part of the "pharmaceutical products" industry.

Alpha Real Trust vs.

Alpha Real Trust (LON:ARTL) and Silence Therapeutics (LON:SLN) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

In the previous week, Alpha Real Trust had 5 more articles in the media than Silence Therapeutics. MarketBeat recorded 5 mentions for Alpha Real Trust and 0 mentions for Silence Therapeutics. Alpha Real Trust's average media sentiment score of 1.26 beat Silence Therapeutics' score of 0.00 indicating that Alpha Real Trust is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Real Trust Positive
Silence Therapeutics Neutral

Silence Therapeutics received 78 more outperform votes than Alpha Real Trust when rated by MarketBeat users. However, 72.67% of users gave Alpha Real Trust an outperform vote while only 68.81% of users gave Silence Therapeutics an outperform vote.

CompanyUnderperformOutperform
Alpha Real TrustOutperform Votes
125
72.67%
Underperform Votes
47
27.33%
Silence TherapeuticsOutperform Votes
203
68.81%
Underperform Votes
92
31.19%

Silence Therapeutics has a net margin of 0.00% compared to Alpha Real Trust's net margin of -10.07%. Silence Therapeutics' return on equity of 0.00% beat Alpha Real Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Real Trust-10.07% -0.75% 1.74%
Silence Therapeutics N/A N/A N/A

Alpha Real Trust has higher earnings, but lower revenue than Silence Therapeutics. Alpha Real Trust is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Real Trust£9.23M13.23£1.28M-£0.02-10,125.00
Silence Therapeutics£11.35M0.00N/A-£48.60N/A

Summary

Alpha Real Trust and Silence Therapeutics tied by winning 5 of the 10 factors compared between the two stocks.

Get Alpha Real Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARTL vs. The Competition

MetricAlpha Real TrustAsset Management IndustryFinancial SectorLON Exchange
Market Cap£122.07M£1.12B£3.87B£2.04B
Dividend Yield3.45%4.65%4.43%5.16%
P/E Ratio-10,125.00810.51428.581,926.65
Price / Sales13.231,498.552,647.34384,006.48
Price / Cash1.7466.0853.1729.21
Price / Book0.981.171.913.08
Net Income£1.28M£61.96M£440.86M£183.60M
7 Day Performance0.35%1.97%2.93%3.09%
1 Month Performance1.25%2.17%5.02%3.42%
1 Year Performance71.61%11.26%15.02%165.41%

Alpha Real Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARTL
Alpha Real Trust
N/AGBX 202.50
+11.9%
N/A+47.5%£122.07M£9.23M-10,125.005News Coverage
High Trading Volume
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020Negative News
IGC
India Capital Growth
N/AGBX 180.50
+0.6%
N/A+3.4%£156.30M£40.31M451.2561Positive News
PHAR
Pharos Energy
N/AGBX 27.30
+0.4%
N/A+38.5%£112.70M£137.60M-910.00280
KOD
Kodal Minerals
N/AGBX 0.40
+1.5%
GBX 1.45
+266.2%
+19.7%£80.19MN/A0.0090News Coverage
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179
AMPH
Aggregated Micro Power
N/AN/AN/AN/A£64.54M£49.33M70.771,620Gap Up
ANW
Aberdeen New Thai Investment Trust
N/AN/AN/AN/A£63.63M£2.08M120.615
REVB
Revolution Beauty Group
N/AGBX 17.63
-1.1%
N/A-49.0%£56.26M£191.29M587.5010Positive News

Related Companies and Tools


This page (LON:ARTL) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners